BioForm has licensed U.S. marketing rights to Aethoxysklerol (R), the worldwide leading sclerotherapy agent, which is currently being evaluated in a Phase III clinical trial. BioForm has also licensed ...

FRANKFURT & SAN MATEO, Calif.--(BUSINESS WIRE)--Merz Pharma Group announced today that the subsequent offering period of the tender offer by Merz GmbH & Co. KGaA (“Merz”) and its acquisition ...

Unless you have been hiding under a rock for the past few weeks, you cannot have missed the hype surrounding the new Bioform bra from Charnos, billed as the ultimate innovation for the larger-busted ...

FRANKFURT, Jan 4 (Reuters) - Germany's family-owned Merz Pharma agreed to buy California-based BioForm Medical for $253 million to bolster its range of supplies for plastic surgeons. Merz said on ...

BioForm Medical Inc. said Wednesday that U.S. regulators approved its skin filler Radiesse to treat facial wrinkles and folds around the nose and upper lip. The Food and Drug Administration also ...

Sept 4 (Reuters) - BioForm Medical Inc , a maker of aesthetic products, reported a wider-than-expected quarterly loss as sales and marketing expenses rose, and forecast fiscal 2009 revenue that may ...